Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,323 | 284 | 67.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,090 | 4 | 32.4% |
| Education | $28.46 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,421 | 85 | $0 (2024) |
| Becton, Dickinson and Company | $1,245 | 4 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $1,129 | 23 | $0 (2024) |
| Novo Nordisk Inc | $770.05 | 71 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $560.84 | 26 | $0 (2020) |
| AbbVie, Inc. | $204.75 | 12 | $0 (2019) |
| Amneal Pharmaceuticals LLC | $143.29 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $127.11 | 9 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $108.19 | 7 | $0 (2024) |
| Abbott Laboratories | $93.24 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $813.73 | 57 | Lilly USA, LLC ($287.28) |
| 2023 | $547.39 | 36 | Lilly USA, LLC ($224.20) |
| 2022 | $44.87 | 3 | Novo Nordisk Inc ($18.09) |
| 2020 | $104.03 | 8 | Lilly USA, LLC ($50.01) |
| 2019 | $253.03 | 15 | AstraZeneca Pharmaceuticals LP ($127.32) |
| 2018 | $2,573 | 80 | Becton, Dickinson and Company ($1,200) |
| 2017 | $2,106 | 93 | Lilly USA, LLC ($556.23) |
All Payment Transactions
292 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Bone Health | ||||||
| 11/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $6.69 | General |
| Category: Growth Hormone | ||||||
| 10/30/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: Growth Hormone | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: DIABETES | ||||||
| 10/02/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Bone Health | ||||||
| 09/16/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Durable Pump | ||||||
| 09/10/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Durable Pump | ||||||
| 08/29/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/21/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/12/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 07/31/2024 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.09 | General |
| Category: Diabetes | ||||||
| 07/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.40 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Neuromodulation | ||||||
| 06/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Bone Health | ||||||
| 06/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 357 | 538 | $181,412 | $46,544 |
| 2022 | 8 | 377 | 721 | $81,517 | $48,997 |
| 2021 | 8 | 471 | 1,089 | $122,526 | $85,224 |
| 2020 | 9 | 482 | 831 | $93,416 | $57,193 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 82 | 123 | $52,275 | $13,674 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 59 | 59 | $32,450 | $8,440 | 26.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 55 | $32,725 | $7,965 | 24.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $29,000 | $6,979 | 24.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 80 | $18,400 | $5,411 | 29.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 16 | $7,280 | $1,780 | 24.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $6,930 | $1,631 | 23.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 67 | 127 | $1,542 | $407.67 | 26.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 25 | 27 | $810.00 | $257.04 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 140 | 228 | $37,776 | $21,852 | 57.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 207 | $17,187 | $12,369 | 72.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 28 | $5,909 | $4,631 | 78.4% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2022 | 27 | 38 | $6,161 | $4,186 | 67.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $6,093 | $3,295 | 54.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 13 | $3,811 | $1,726 | 45.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 46 | 52 | $1,310 | $499.99 | 38.2% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 77 | 135 | $3,271 | $438.67 | 13.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 155 | 334 | $53,968 | $34,591 | 64.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 266 | $20,767 | $16,614 | 80.0% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2021 | 62 | 120 | $19,498 | $14,458 | 74.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 45 | $9,792 | $7,834 | 80.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $13,291 | $7,654 | 57.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 12 | 18 | $3,658 | $2,740 | 74.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 50 | 73 | $754.70 | $708.83 | 93.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 82 | 190 | $796.96 | $623.20 | 78.2% |
About Dr. Ari Eckman, MD
Dr. Ari Eckman, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1386859585.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ari Eckman, MD has received a total of $6,442 in payments from pharmaceutical and medical device companies, with $813.73 received in 2024. These payments were reported across 292 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,323).
As a Medicare-enrolled provider, Eckman has provided services to 1,687 Medicare beneficiaries, totaling 3,179 services with total Medicare billing of $237,957. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Teaneck, NJ
- Active Since 05/11/2007
- Last Updated 08/02/2024
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1386859585
Products in Payments
- SOLIQUA (Drug) $938.42
- HUMULIN (Drug) $766.14
- FARXIGA (Drug) $560.84
- MOUNJARO (Drug) $362.44
- Victoza (Drug) $359.56
- Saxenda (Drug) $189.93
- UNITHROID (Drug) $143.29
- JARDIANCE (Drug) $136.30
- Androgel (Drug) $105.56
- Synthroid (Drug) $99.19
- JANUVIA (Drug) $93.38
- EVENITY (Biological) $85.79
- Ozempic (Drug) $82.52
- TOUJEO (Drug) $82.50
- Omnipod (Device) $73.36
- MINIMED 780G (Device) $72.98
- Minimed 670G System (Device) $71.57
- Somatuline Depot 120mg-.5ml (Drug) $54.40
- TZIELD (Biological) $53.96
- RECORLEV (Drug) $44.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Teaneck
Dr. Atara Schultz, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $368,637
Dr. Mark Wiesen, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $34,099
Dr. Deeksha Mehta, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $308.07